In August, Celestica [CLS 0.00%↑] sold 11.1M new shares at $310 to fund its next leg of growth. On October 27 it told you what that leg looks like: $40B of revenue in 2027, +90% on this year, and adjusted EPS of $21.50. As I write this, the same shares cost $258, 17% below what the new shareholders paid less than three months ago.